|
original article |
Journal |
Date |
Title |
Authors All Authors |
1 |
[GO] |
Tuberculosis and Respiratory Diseases |
2022―Mar―23 |
Confocal laser endomicroscopy in a critically ill COVID-19 patient |
Olesya Danilevskaya, Dmitry Sazonov, Tatyana Klypa, Fedor Zabozlaev, Elena Popova |
2 |
[GO] |
Tuberculosis and Respiratory Diseases |
2021―Nov―30 |
Association between inhaled corticosteroid use and SARS-CoV-2 infection: A nationwide population-based study in South Korea |
Sang Chul Lee, Kang Ju Son, Chang Hoon Han, Ji Ye Jung, Seon Cheol Park |
3 |
[GO] |
Tuberculosis and Respiratory Diseases |
2021―Nov―15 |
COPD is not associated with a poor prognosis in COVID-19 |
Youlim Kim, Tai Joon An, Yong Bum Park, Kyungjoo Kim, Do Yeon Cho, Chin Kook Rhee, Kwang-Ha Yoo |
4 |
[GO] |
Tuberculosis and Respiratory Diseases |
2021―Oct―20 |
Chest film demonstrating reverse batwing pulmonary opacities in a patient with COVID-19 pneumonia |
Chih-Jung Chang, Sheng-Wei Pan, Yuh-Min Chen |
5 |
[GO] |
Tuberculosis and Respiratory Diseases |
2021―Aug―03 |
SARS-CoV-2 sequel: Pulmonary mucormycosis with a mycotic aneurysm in a transplant recipient |
Klein Dantis, Vinay Rathore, Nitin Kumar Kashyap, Nilesh Gupta, Sajal De |
6 |
[GO] |
Tuberculosis and Respiratory Diseases |
2021―May―27 |
Dexamethasone and COVID-19 in a developing country: Appropriate use? |
Diego Martin Moreno Marreros, Maycol Leonardo Aburto Moreno, Kattia Gassely Torres Gil, Carlos Morera Guzman |
7 |
[GO] |
Tuberculosis and Respiratory Diseases |
2021―May―21 |
Efficacy and Safety of Azithromycin for the Treatment of COVID-19: A Systematic Review and Meta-analysis |
Ghea Mangkuliguna, Natalia Susanto, Laurentius A. Pramono |
8 |
[GO] |
Tuberculosis and Respiratory Diseases |
2021―Apr―25 |
The effect of the timing of dexamethasone administration in patients with COVID-19 pneumonia |
Hyun Woo Lee, Jimyung Park, Jung-Kyu Lee, Tae Yeon Park, Eun Young Heo |
9 |
[GO] |
Tuberculosis and Respiratory Diseases |
2021―Apr―02 |
Predictors of worsening COVID-19 illness |
Beuy Joob, Viroj Wiwanitkit |
10 |
[GO] |
Tuberculosis and Respiratory Diseases |
2021―Mar―29 |
The effect of the timing of dexamethasone administration in patients with COVID-19 pneumonia |
Hyun Woo Lee, Jimyung Park, Jung-Kyu Lee, Tae Yeon Park, Eun Young Heo |
11 |
[GO] |
Tuberculosis and Respiratory Diseases |
2021―Mar―17 |
Experience of treating critically ill COVID-19 patients in Daegu, South Korea |
Kyeong-Cheol Shin |
12 |
[GO] |
Tuberculosis and Respiratory Diseases |
2021―Mar―11 |
Predictors of worsening oxygenation in COVID-19 |
Jee Youn Oh |
13 |
[GO] |
Tuberculosis and Respiratory Diseases |
2021―Jan―06 |
Factors associated with worsening oxygenation in patient with non-severe COVID-19 pneumonia |
Cho Rom Hahm, Young Kyung Lee, Dong Hyun Oh, Mi Young Ahn, Jae-Phil Choi, Na Ree Kang, et al. (+3) Jungkyun Oh, Hanzo Choi, Suhyun Kim |
14 |
[GO] |
Tuberculosis and Respiratory Diseases |
2020―Dec―28 |
Association between oxygen saturation/fraction of inhaled oxygen and mortality in patients with COVID-19 associated pneumonia requiring oxygen therapy |
Keum-Ju Choi, Hyo-lim Hong, Eun Jin Kim |
15 |
[GO] |
Tuberculosis and Respiratory Diseases |
2020―Oct―30 |
Risk factors for mortality among hospitalized patients with COVID-19. An overview in Mexican population |
Arturo Cortés-Tellés, Stephanie López-Romero, Roberto Mancilla-Ceballos, Diana Lizbeth Ortíz-Farías, Nelda Núñez-Caamal, Esperanza Figueroa-Hurtado |
16 |
[GO] |
Tuberculosis and Respiratory Diseases |
2020―Oct―26 |
Are patients with asthma and COPD preferred targets of COVID-19? |
Belaid Bouazza, Dihia Hadj-Said, Karen A. Pescatore, Rachid Chahed |
17 |
[GO] |
Tuberculosis and Respiratory Diseases |
2020―Oct―08 |
COVID-19 death and BCG vaccination |
Viroj Wiwanitkit |
18 |
[GO] |
Tuberculosis and Respiratory Diseases |
2020―Sep―04 |
COVID-19 death and BCG vaccination programs worldwide |
Feras J Jirjees, Yahya H Dallal Bashi, Hala J. Al-Obaidi |